Results 171 to 180 of about 7,987 (192)

Apatinib induced ferroptosis by lipid peroxidation in gastric cancer

Gastric Cancer, 2021
Guoxin Li, Xuetao Lei, Ziqing Wang
exaly  

Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Camrelizumab and Apatinib in Patients With Resectable NSCLC: A Phase 2 Clinical Trial

Journal of Thoracic Oncology, 2023
Shugeng Gao, Xiuli Tao
exaly  

Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A Multicenter, Two-Stage, Phase 2 Trial

Journal of Thoracic Oncology, 2021
Haihua Yang, Yun Fan, Yi Hu
exaly  

Apatinib enhanced anti-PD-1 therapy for colon cancer in mice via promoting PD-L1 expression

International Immunopharmacology, 2020
Qiang Xu, Xiaofeng Chen, Wenjie Guo
exaly  

People also looked at

Frontiers in Oncology, 2022
Huanlong Qin, Tongyi Shen, Dengdeng Pan
exaly  

People also looked at

Frontiers in Oncology, 2020
Feng Pan, Yanqiao Ren, Chuansheng Zheng
exaly  

Astragalus polysaccharide enhanced antitumor effects of Apatinib in gastric cancer AGS cells by inhibiting AKT signalling pathway

Biomedicine and Pharmacotherapy, 2018
Junxian Yu, Xiao-Jun Yao, Bangwei Cao
exaly  

A phase II study of apatinib in patients with recurrent epithelial ovarian cancer

Gynecologic Oncology, 2018
Jiajia Zhou
exaly  

Clinical response to apatinib monotherapy in advanced non-small cell lung cancer

Asia-Pacific Journal of Clinical Oncology, 2018
Yuankai Shi, Xiangru Zhang
exaly  

An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202)

Therapeutic Advances in Medical Oncology, 2020
Diansheng Zhong, Ruixing Zhang, Xiubao Ren   +2 more
exaly